A systematic review of herbal medicinal products for the treatment of menopausal symptoms
- 1 September 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Menopause
- Vol. 10 (5) , 465-476
- https://doi.org/10.1097/01.gme.0000058147.24036.b0
Abstract
Many women have turned to complementary and alternative medicines for relief from their menopausal symptoms. The prevalence of herbal medicinal product use among menopausal women highlights the need for investigation into these interventions. The aim of this study was to evaluate the benefit of herbal medicinal products for the treatment of menopausal symptoms by performing a systematic review of randomized clinical trials. Literature searches of four computerized databases were done to identify randomized clinical trials of herbal medicinal products for the treatment of menopausal symptoms. Manufacturers of herbal products were contacted, and our own files were also searched. There were no restrictions on the language of publication. Trials were considered if the outcome measures related to the physical or psychological impact of menopause, whether by compendium scores, questionnaires, or women's symptom diaries, excluding studies describing artificially induced menopause. This review was not concerned with biochemical or pathological data. Eighteen randomized clinical trials that fit our criteria were identified. These studies investigated black cohosh (n = 4), red clover (n = 4), kava (n = 3), dong quai (n = 1), evening primrose oil (n = 1), ginseng (n = 1), and combination products (n = 4). Trial quality was generally good, with 16 of 18 studies scoring 3 or more (maximum 5) on the Jadad Scale. There is no convincing evidence for any herbal medical product in the treatment of menopausal symptoms. However, the evidence for black cohosh is promising, albeit limited by the poor methodology of the trials. The studies involving red clover suggest it may be of benefit for more severe menopausal symptoms. There is some evidence for the use of kava, but safety concerns mean this herbal product is not a therapeutic option at present. The evidence is inconclusive for the other herbal medicinal products reviewed.Keywords
This publication has 17 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Randomized Trial of Black Cohosh for the Treatment of Hot Flashes Among Women With a History of Breast CancerJournal of Clinical Oncology, 2001
- Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in womenClimacteric, 1999
- The effect of Promensil™, an isoflavone extract, on menopausal symptomsClimacteric, 1999
- Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trialFertility and Sterility, 1997
- Alternative drug use for the climacteric in FinlandMaturitas, 1997
- The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish populationActa Obstetricia et Gynecologica Scandinavica, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- A PROSPECTIVE, CONTROLLED TRIAL OF SIX FORMS OF HORMONE REPLACEMENT THERAPY GIVEN TO POSTMENOPAUSAL WOMENBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- CONTEMPORARY THERAPY OF THE MENOPAUSAL SYNDROMEJAMA, 1959